Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$589K Sell
296
-1
-0.3% -$1.59K 0.09% 222
2026
Q1
$392K Hold
297
0.06% 271
2025
Q4
$318K Sell
297
-29
-9% -$30.3K 0.05% 308
2025
Q3
$316K Buy
326
+2
+0.6% +$1.57K 0.04% 332
2025
Q2
$260K Buy
+324
New +$233K 0.04% 352
2024
Q4
Sell
-270
Closed -$225K 362
2024
Q3
$225K Sell
270
-30
-10% -$26.8K 0.04% 346
2024
Q2
$307K Hold
300
0.06% 234
2024
Q1
$291K Hold
300
0.06% 240
2023
Q4
$227K Buy
+300
New +$198K 0.05% 259
2023
Q3
Sell
-300
Closed -$217K 281
2023
Q2
$217K Hold
300
0.05% 283
2023
Q1
$204K Buy
+300
New +$193K 0.05% 291

Other funds holding ASML

Chicago Trust's ASML Position: Q2 2026 in Review

Chicago Trust reduced its ASML (ASML) stake by 0.34% in Q2 2026, selling an estimated $1.59K and leaving 296 shares worth $589K. The position accounts for 0.09% of the portfolio, ranked #222.

Chicago Trust first reported a position in ASML in Q1 2023 and has held it in 11 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Chicago Trust held 296 shares of ASML worth $589K as of Q2 2026.
  • Chicago Trust sold 1 ASML share in Q2 2026, an estimated $1.59K.
  • ASML made up 0.09% of Chicago Trust's portfolio in Q2 2026, its #222 holding.
  • Chicago Trust first reported a position in ASML in Q1 2023 and has held it in 11 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.